Skip to main content
Gut Microbes logoLink to Gut Microbes
. 2013 Aug 28;4(6):494–504. doi: 10.4161/gmic.26277

Unintended consequences of Helicobacter pylori infection in children in developing countries

Iron deficiency, diarrhea, and growth retardation

Dulciene MM Queiroz 1, Andreia MC Rocha 1, Jean E Crabtree 2,*
PMCID: PMC3928161  PMID: 23988829

Abstract

Helicobacter pylori infection is predominantly acquired early in life. The prevalence of the infection in childhood is low in developed countries, whereas in developing countries most children are infected by 10 y of age. In poor resource settings, where malnutrition, parasitic/enteropathogen and H. pylori infection co-exist in young children, H. pylori might have potentially more diverse clinical outcomes. This paper reviews the impact of childhood H. pylori infection in developing countries that should now be the urgent focus of future research. The extra-gastric manifestations in early H. pylori infection in infants in poor resource settings might be a consequence of the infection associated initial hypochlorhydria. The potential role of H. pylori infection on iron deficiency, growth impairment, diarrheal disease, malabsorption and cognitive function is discussed in this review.

Keywords: Helicobacter pylori, children, hypochlorhydria, iron deficiency, diarrhea, growth retardation, malabsorption, cognitive impairment, developing countries

Introduction

Helicobacter pylori colonizes the stomach of more than a half of the world’s population and its acquisition occurs predominantly in early childhood, especially in preschool age.1 In developed countries, the prevalence of H. pylori infection is low in childhood whereas in developing countries most children are infected by 10 y of age.1,2 In some settings such as Peru shanty towns over 70% of infants are infected in the first year of life3,4 but in other similar settings in South America H. pylori infection occurs between 1–5 y of age.2,4 In poor resource settings where the infection co-exists with other morbidities such as malnutrition and parasitic and enteropathogen infections, H. pylori infection in young children may have potentially more diverse clinical outcomes than in developed countries, and include not only iron deficiency or iron deficiency anemia but growth retardation, diarrheal disease, malabsorption and impaired cognitive function.

This review focuses on the impact of childhood H. pylori infection in poor resource settings. With rapidly falling levels of H. pylori infection in children in developed countries, childhood H. pylori infection in developing countries, where infection in early childhood remains high, should now be the urgent focus of future research. Importantly, the extra-gastric manifestations of H. pylori infection as a consequence of the initial hypochlorhydria associated with H. pylori infection5 have been little investigated in developing countries. The potential role of H. pylori on iron deficiency, growth impairment, diarrheal disease, malabsorption and cognitive function is discussed in this review. Although these are all potential extra-gastric manifestations of H. pylori infection, recent evidence points to the importance of hypochlorhydria6 and proinflammatory IL-1β gene cluster polymorphisms7 in iron deficiency in H. pylori infected children. The consequences of hypochlorhydria in early H. pylori infections in infants in poor resource settings may also be central to increased diarrheal disease, growth impairment, malabsorption and impaired cognitive function (Fig. 1). H. pylori infection in developing countries could be initiating a vicious cycle of events in infants,5 the global impact of which on childhood morbidity may be diverse, and largely a consequence of extra-gastric manifestations of H. pylori infection.

graphic file with name gmic-4-494-g1.jpg

Figure 1. Potential multiple outcomes of childhood H. pylori infection in developing countries. Infection with H. pylori is frequent in children in developing countries.2H. pylori infection is accompanied by a period of hypochlorhydria for several months. Hypochlorhydria in H. pylori infected children has been associated with iron deficiency.6 Polymorphisms in IL-1β gene cluster may control the extent and duration of hypochlorhydria with initial H. pylori infection. Pro-inflammatory polymorphisms in the IL-1β gene cluster in H. pylori infected children are associated with hypoferritinaemia and reduced hemoglobin concentrations.7 The period of hypochlorhydria associated with H. pylori infection in poor resource settings is a potential window for the acquisition of other enteric infections and diarrheal disease.90,91 The clinical consequences and potential synergism between H. pylori infection and diarrheal disease in poor resource settings will promote not only malnutrition and growth impairment, but also cognitive impairment.150 The hypochlorhydria induced by H. pylori infection may also result in alterations in the gut microbiota and contribute to small intestinal permeability changes and malabsorption, thus also impacting on malnutrition and growth impairment.

H. pylori and Iron Deficiency

Iron deficiency (ID), the most common nutritional disorder in the world, affects 20–50% of people globally,8-11 iron deficiency anemia (IDA) being the final stage in the spectrum of a persistent negative iron balance. In developing countries, anemia represents a major public health problem and approximately 50 percent of all cases are due to ID.9,11 Factors including low iron intake, low dietary iron bioavailability and gastrointestinal parasite infections contribute to the high frequency of ID/IDA in developing countries.11,12 In childhood/adolescence the increased requirement for iron due to growth, expansion of red cell mass and menstrual blood loss in adolescent females favors the development of ID/IDA.11,13,14 In childhood, iron deficiency has been associated with deficits of immune, cognitive and motor function.11,15,16 Clinically advanced IDA is associated with reduced growth, increased susceptibility to infectious diseases and increased mortality.10,17

The first descriptions of an association between IDA and H. pylori infection in children were case reports published in 1991 by Blecker et al.17 of a 15-y-old girl with a chronic active hemorrhagic gastritis associated with H. pylori infection and in 1993 by Dufour et al.19 of a 7-y-old boy with H. pylori chronic antral gastritis without hemorrhage. These two patients had IDA that was refractory to iron therapy in the boy.19 Eradication of H. pylori without iron supplementation resulted in reversion of the anemia in both cases. Since then, other case reports and series of cases have demonstrated an improvement in iron parameters after eradication of H. pylori in children.20-22

Epidemiological studies

Several observational epidemiological studies in children demonstrating an association between H. pylori infection and lower serum ferritin concentrations and/or increased prevalence of iron deficiency23-28 have reinforced the association between H. pylori infection and impaired iron status. Studies conducted in developed23-27 and developing28 countries showed lower serum ferritin concentrations23,24,26,27 and/or higher proportion of ID or IDA25-28 in H. pylori-positive than in H. pylori-negative children.

Of note, in a large cohort of 937 pubescent children in South Korea,23a higher H. pylori-positive serology rate in those with either hypoferritinemia or ID/IDA was largely restricted to girls, which might be explained by lower iron storage in females. In 1040 children and adolescents29 and in nearly 700 school-aged Alaskan children,25 where H. pylori status was evaluated by ELISA or 13C urea breath test (13C-UBT), an increased risk for low serum ferritin concentrations29 or increased prevalence of ID in children older than 8 y of age25 was observed in H. pylori infected than in non-infected children. Cardenas et al.26 by evaluating 1,771 children and adolescents among 7,462 subjects from the 1999–2000 USA National Health and Nutrition Examination Survey (NHANES) showed that positive serology for H. pylori was associated with decreased levels of serum ferritin and hemoglobin and increased risk for IDA. The authors estimated that 32.3% of the cases of IDA and 13.6% of ID in the United States might be related to H. pylori infection. In poor resource settings the contribution of H. pylori to ID may well be greater.

In a cross-sectional study evaluating symptomatic South-American children undergoing upper gastrointestinal endoscopy, H. pylori infection was also a significant predictor of low serum ferritin and hemoglobin concentrations.30 Negative correlations between mean cell volume (MCV) and mean cell hemoglobin (MCH) values and the degree of antral and corpus inflammation were also observed in the Brazilian and Chilean children.30 An association between H. pylori infection and reduced serum ferritin levels was also found in children from Turkey undergoing endoscopy.31

Other studies in children have failed to demonstrate associations between H. pylori infection and iron/anemia parameters.32-35 Explanations include differences in study design, inclusion/exclusion criteria, number and age of the evaluated children, H. pylori diagnosis criteria and adjustment for confounding factors. For instance, very few studies have investigated children undergoing endoscopy for upper gastrointestinal symptoms,30,31,36 a strategy which permits better evaluation of H. pylori status and the exclusion of common causes of iron deficiency such as gastrointestinal bleeding, peptic ulcer disease, extensive erosions and celiac disease. Exclusion of female adolescents with heavy menstrual blood loss,30 an important determinant of iron status in young women, and intestinal parasitic infections6,30 that lead to blood loss have not been adopted by all authors. Exclusion of subjects with enteric parasitic infection is vital in studies on H. pylori infection and iron deficiency in developing countries. The choice of diagnostic methods for H. pylori infection may also contribute to disagreement among the studies. Indirect methods such as serology have a low accuracy rate for the diagnosis of H. pylori in young children.37

Interventional clinical trials

The strongest evidence for a cause-and-effect comes from interventional trials in children from developed38-40 and developing countries41-44 or from low socioeconomic populations in a developed country45 that demonstrated an improvement of the anemia after H. pylori eradication. A series of therapeutic trials in children without iron replacement in South Korea demonstrated improvement of hemoglobin and/or ferritin levels after H. pylori eradication.38-40 In a controlled, household-randomized trial in rural Alaska, Fagan et al.,42 by evaluating 176 native school-age children, demonstrated higher ferritin concentrations in children who remained H. pylori negative at 40 mo after H. pylori eradication therapy than in children who were re-infected with H. pylori, or who were untreated for H. pylori. Eradication of H. pylori in 110 Hispanic children of low socio-economic level aged 3 to 10 y without ID was accompanied by 3-fold increased serum ferritin baseline values.45 However, Sarker et al.46 did not observe differences in the hemoglobin concentrations and iron parameters between Bangladeshi children with IDA or ID in whom H. pylori was eradicated and children who remained H. pylori-positive in the three months-follow-up.

Two meta analyses studies including 16 and 8 randomized controlled trials47,48 conducted in Asian children and adults, and one trial in Alaska,47 compared the effect of oral iron supplementation alone, or in combination with H. pylori eradication therapy, on hematological parameters in patients with iron deficiency anemia. The meta analyses indicated eradication of H. pylori with oral iron significantly increased hemoglobin, serum ferritin47,48 and serum iron47 from baseline compared with oral iron therapy alone. The meta analyses confirm that oral iron alone has no beneficial effect on serum iron, hemoglobin and serum ferritin in the absence of H. pylori eradication. This indicates that gastric H. pylori infection is perturbing the normal physiological mechanisms of iron absorption.

An important question is whether eradication of H. pylori infection to improve iron status in children in developing countries could have adverse effects. Recent important studies in Tanzanian children indicate that the iron status influences Plasmodium falciparum malaria risk.49 Iron deficiency was associated with significantly reduced parasitemia and severity of malaria and malaria-associated mortality.49 In areas of high malaria risk H. pylori may have a beneficial role protecting from severe parasitaemia. H. pylori eradication in such areas for iron deficiency should only be undertaken in associated with effective malaria control.

Mechanisms of ID/IDA due to H. pylori infection

The mechanisms by which H. pylori infection might cause ID/IDA have not been well defined. Increased blood loss due to H. pylori-induced gastric lesions, deficient iron absorption due to decreased gastric acidity/gastric juice ascorbic acid concentrations and iron uptake by H. pylori have been proposed.

Erosive gastritis

Occult blood loss due to chronic erosive/hemorrhagic gastritis was one of the first supposed mechanisms of ID in H. pylori infection.18 However, it does not appear to be the most relevant factor because neither gastric bleeding lesions are frequently found in H. pylori-positive children undergoing endoscopy,19,20,38,40 nor is the faecal occult blood test positive in the patients.19,40

Deficient iron absorption and reduced gastric juice ascorbic acid

Another proposed mechanism promoting ID in H. pylori infection involves deficient iron absorption due to decreased gastric acidity.5,50 Gastric acid is essential for iron absorption as it reduces ferric iron to the more soluble and absorbable ferrous iron form.50 It has been demonstrated that H. pylori infected children have significantly lower basal and stimulated acid output than uninfected children and that eradication of H. pylori infection improves gastric acid output.51 In addition, in Chilean children infected with H. pylori an association between hypochlorhydria and low serum iron and transferrin was observed.6

Initial H. pylori infection is accompanied by a period of hypochlorhydria of variable duration.52-54 This could be linked to increased concentrations of IL-1β and TNF-α, potent inhibitors of gastric acid secretion by parietal cells,55 in the gastric mucosa of H. pylori infected adults and children.56-58 Similar perturbations in gastric acid secretion occur in animals following infection with gastric Helicobacter species.59,60 In the study of Takashima et al.60 in gerbils, treatment with recombinant IL-1 receptor antagonist reversed the hypochlorhydria induced by H. pylori infection implicating the IL-1B gene cluster in the hypochlorhydric response to H. pylori. Clinically the duration of hypochlorhydria is variable but experimental human infection studies indicate hypochlorhydria can extend for several months.61 Data from infants in Gambia, using a non-invasive urinary test of gastric acid secretion,62 similarly indicate H. pylori infected infants have extended periods of hypochlorhydria.63

As H. pylori infection is mainly acquired in childhood,1 it is plausible that infected children with hypochlorhydria may be at increased risk of developing ID/IDA. In fact, a recent study evaluating a cohort of symptomatic Brazilian children undergoing upper gastrointestinal endoscopy7 demonstrated that the concentration of gastric IL-1β was inversely associated with blood ferritin and hemoglobin concentrations, suggesting that in the early phase of H. pylori infection, high gastric secretion of IL-1β inhibits acid secretion and impairs the absorption of iron. IL1β could also participate in the impairment of iron absorption by upregulating hepcidin as demonstrated in vivo.64,65 However, association between the serum concentrations of hepcidin and H. pylori infection has not been observed.66

In long-term chronic H. pylori infection in adults, hypochlorhydria resulting from development of gastric atrophy with loss of parietal cells is considered an important mechanism of iron deficiency.67,68 Gastric corpus atrophy in H. pylori infected adults is more frequently observed in carriers of the IL1 gene cluster polymorphisms.57 In Brazilian children it was demonstrated that hemoglobin and hematocrit values are lower in carriers of IL1RN polymorphic alleles than in children with the wild genotype.7 High gastric secretion of IL-1β in the former group might cause more severe hypochlorhydria in the acute phase of H. pylori infection that is mainly acquired in early childhood.

Decreased gastric juice ascorbic acid concentrations have also been considered to contribute to deficient iron absorption in H. pylori-infected patients. Ascorbic acid maintains iron stability by chelating ferric iron as well as participating in the maintenance of iron in the more absorbable ferrous form.50 Baysoy et al.69 demonstrated decreased gastric juice ascorbic acid concentrations in H. pylori positive children, especially in those infected with cagA-positive strains. However, there were no differences in ascorbic acid concentrations between H. pylori infected children with, and without, IDA. However, an association between low gastric juice ascorbic acid and IDA in adults infected by H. pylori has been demonstrated.67

Finally, H. pylori-positive children69 and adults70 with IDA have more frequently a pattern of gastritis with corpus involvement that is accompanied by decreased gastric acid secretion that could impair iron absorption. Baysoy et al.69 observed lower serum iron concentrations in infected children with pangastritis than in those with antral gastritis.

Iron-uptake by H. pylori

H. pylori has a high affinity uptake system to scavenge iron from the host with many proteins, such as FeoB, FrpB, iron-repressible outer membrane proteins (IROMPs), Pfr and NapA involved in the transport/storage of the metal,71-76 and the Fur protein, encoded by the fur gene, involved in ferric uptake regulation.77 The sources of iron that H. pylori utilizes during colonization are not clear, but uptake of ferrous iron by FeoB75,76 and heme uptake by heme/hemoglobin-binding proteins such as FrpB276,78 and IROMPs72,79 have been demonstrated.

Iron uptake from host transferrin76,80 and lactoferrin73 have also been described. In the process of iron acquisition from transferrin, the virulence factors, VacA and CagA, are involved in the relocation of the transferrin/transferrin receptor from the basolateral to the apical surface of the gastric epithelial cell where the iron can be utilized by H. pylori.81 Importantly, experimental studies indicate that only CagA-positive H. pylori strains are able to colonize iron deficient gerbils.81 This raises the intriguing question of whether the high prevalence of cag pathogenicity island (cag PAI) positive H. pylori strains in many developing countries is a consequence of high levels of iron deficiency in the respective populations.

It seems that some H. pylori strains have enhanced iron-uptake activity as demonstrated by Yokota et al.82 who compared strains isolated from patients with IDA to those from patients without IDA. The authors postulated that the high ability of H. pylori to uptake iron might be a causative factor for iron-deficiency anemia. Corroborating this finding, the expression of IROMPs under iron restricted conditions is higher in H. pylori strains isolated from patients with IDA than from those without IDA.79

The proteomic profiles of H. pylori strains isolated from patients with IDA seems to be different from those isolated from patients without IDA,83 suggesting that polymorphisms in genes that encode proteins involved in H. pylori iron acquisition might influence the development of ID in the host. The Thr70-type polymorphism in napA that encodes a bacterioferritin-like protein was associated with enhanced Fe iron uptake and occurred more frequently in strains isolated from Japanese patients with, than in those without, iron-deficiency.84 Other polymorphisms in the napA gene have also been more frequently observed in strains isolated from IDA Korean adolescents.85 Polymorphisms in the H. pylori feoB gene86 that encodes FeoB, a high-affinity cytoplasmic membrane Fe+2 transporter protein, were reported to associate with IDA in Korean children, but not in adult Japanese patients. Polymorphisms in other Helicobacter genes such as pfr87 that encodes a prokaryotic ferritin and fur,84 a transcription repressor of iron acquisition systems, were not significantly associated with IDA.

High lactoferrin concentrations, which decreased after eradication of H. pylori, were observed in the gastric mucosa of H. pylori positive Korean adolescents with IDA compared with those without anemia, or in non-infected adolescents with IDA.88 This points to lactoferrin sequestration in the gastric mucosa as another potential mechanism of iron deficiency associated with H. pylori infection.

H. pylori and Diarrheal Disease

The importance of gastric acid in preventing enteric infections is well established.89,90 Although some bacterial pathogens are less susceptible to gastric acid,91 hypochlorhydria increases the risk of several infections including cholera,92 typhoid and non-typhoidal salmonellosis93 and enteric viruses.94 In developed countries pharmacological induced hypochlorhydria is a recognized risk factor for Clostridium difficile-associated diarrhea.95

In developing countries where enteric infections are endemic, the hypochlorhydria associated with initial H. pylori infection in infants and children, which can last several months, may be a critical window for acquisition of other enteropathogens and diarrheal disease (Fig. 1). Few studies have examined the impact of initial H. pylori infection in infants and children on diarrheal disease. Early studies in Gambian infants identified an association between H. pylori seropositivity and chronic diarrhea.96 In Lima, Peru H. pylori seroconverting infants and children had increased diarrhea days and diarrhea episodes in the year after H. pylori infection than uninfected children.97 Interestingly, the effects of H. pylori on diarrheal disease were greatest in the two months after infection,97 the period when post-infection hypochlorhydria would be most evident.

The risk of co-infection with specific enteropathogenic infections in H. pylori positive children and/or adults has also been investigated in developing countries. In Peru H. pylori positivity has been associated with increased Vibrio cholerae infection in young children under 10 y of age98 and adults with chronic atrophic gastritis,99 the latter study emphasing the important protective role of gastric acidity. In contrast, studies in Bangladeshis involving both children and adults have found no increase in cholera in H. pylori infected subjects;100 however, evaluation of gastric pathology was not undertaken and the period of acute H. pylori infection was not specifically evaluated. H. pylori infection has also been associated with increased Shigella infection in young children101 and Salmonella typhi in adults.102

In contrast to the studies in Peru97 and Gambia,96 a study in Thai children did not observe an association between H. pylori infection and increased diarrheal disease.103 Furthermore, studies in adults in two developed countries, USA and Germany, found a negative association between H. pylori infection and gastroenteritis.104,105 The conflicting results between developed and developing countries is unsurprising given the contrasting exposure to enteric pathogens and differing availability of clean water and sanitation. Further studies are required in infants and children to assess the role of H. pylori in childhood diarrheal disease in developing countries.

H. pylori and Growth Retardation

There is considerable variation in the results of studies evaluating the effect of H. pylori infection on growth in children. Cross-sectional studies in different countries points to the presence24,106-113 or absence114-121 of association. There are other studies demonstrating associations only in the presence of iron-deficiency or dyspeptic symptoms.122,123 However, almost all longitudinal studies analyzing growth velocity, considered a more sensitive indicator of health status than weight and height,124 point to association.124-128 Recently, new evidence on the role of H. pylori infection on growth emerged from the studies of Mera et al.129 and Yang et al.130 who demonstrated a beneficial effect of eradication of H. pylori on the growth of children from Colombia and China, respectively. However, only one study127 has examined childhood growth in the first two years of life, when the greatest impact of infection on growth is expected to occur and no birth-cohort studies have been conducted until recently.

Most of the cross-sectional studies evaluating differences in the height-for-age, weight-for-age, or the frequency of short stature, according to H. pylori status are from developing countries. In most studies, no adjustment for genetic factors and socioeconomic status, which are known to influence childhood growth, was done. Association between H. pylori infection and short stature was observed in prepubescent girls from a low income community in northeast Brazil,110 in Egyptian children111 and in children from low resource setting in Mexico.112 Results of studies from Turkey are controversial: a negative effect of H. pylori infection on growth31,108,113 and no association,117,119 or associations only in children with recurrent abdominal pain123 were observed. Absence of an association between height and H. pylori infection were described in Alaska native children;118 in African refugee children from Australia;120 in dyspeptic children from Iran121 and in children from Guatemala.116

In developed countries, studies from Italy,106 Germany,107 and Japan109 also point to negative effects of H. pylori infection on growth in childhood. However, no difference in the prevalence of H. pylori infection could be detected in Italian children with short stature114,115 as well as no difference in the weight and height could be demonstrated in children from UK after adjusting for socioeconomic factors.131

Longitudinal cohort studies evaluating children from Colombia124,126,132 and Ecuador128 demonstrate reduction on the velocity of growth associated with acquisition of H. pylori infection as diagnosed by urea breath test and stool antigen test. Of note, the associations remained significant after controlling for confounding variables linked to socio-economic status.

Bravo et al.126 demonstrated that the deceleration of growth velocity occurs one to two months after acquisition of the infection, independently of the age of the children, and the final effect of H. pylori infection on the growth velocity was 0.5 cm/year. Mera et al.132 observed that the reduction on growth velocity was significant for up to 6 mo after acquisition of H. pylori and after 8 mo the cumulative difference between H. pylori-positive and -negative children was 0.25 cm. In the study of Goodman et al.124 H. pylori-positive children grew an average of 0.022 cm/month slower than the non-infected children. Egorov et al.128 observed a reduction in the linear growth velocity of 9.7 mm/year in children with new H. pylori infection compared with uninfected children and 6.4 mm/year compared with children with chronic H. pylori infection.

Reduction in growth velocity associated with acquisition of the infection, evaluated by urea breath test and controlled for socioeconomic and demographic variables, in two cohorts of children from Gambia was transiently observed in children who acquired H. pylori infection early, at 3/6 mo of age, but reduced growth velocity was no longer detected when the children were 5 to 8 y old.127 In developed countries, Patel et al.,125 by evaluating 554 Scottish children, demonstrated that the growth of H. pylori-positive girls after four years follow-up was significantly lower than that of the uninfected girls.

Recently, two interventional studies129,130 demonstrated that eradication of Helicobacter pylori increases childhood growth. In Colombia, the authors showed that although no difference in the height between H. pylori-positive and -negative children could be detected at baseline, in the 3.7 y follow-up, treated but not untreated children were 2.98 cm taller, after adjusting for demographic and socioeconomic variables.129 In another study, Yang et al.130 found that Taiwanese children with successful eradication of the bacterium had higher height and weight than the non-infected ones.

The mechanism by which H. pylori causes growth impairment in children remains to be investigated. Whether growth failure is a direct effect of the H. pylori-induced inflammation or a consequence of indirect effects such as infection-induced anorexia, H. pylori-associated intestinal permeability changes/malabsorption or diarrheal disease is unclear. The likelihood is both direct and indirect effects will contribute to growth impairment. Experimental studies on inflammation induced animal models of colitis indicate IL-6, which suppresses insulin-like growth factor (IGF-1), mediates growth failure.133 Further studies are required to determine whether IL6 -174 G/C promoter polymorphisms associated with growth failure in children with Crohn disease133 impact on growth impairment in infants/children with H. pylori infection.

Does H. pylori Infection Contribute to Malabsorption?

Mucosal small intestinal enteropathy and associated chronic permeability changes in infants in developing countries are considered a major factor in growth retardation.134 The precise mechanisms of small intestinal mucosal damage contributing to malabsorption and its association with diarrhea and growth retardation has long been debated and subject of recent comprehensive reviews.135,136 To date no specific pathogens have been associated with enteropathy and malabsorption. The hypochlorhydria associated with initial H. pylori infections in infants in developing countries may result in establishment of small intestinal bacterial flora and lead, via microbial disturbances of intestinal barrier function, to changes in small intestinal permeability (Fig. 1). Whether such changes in intestinal microbiota resolve following restoration of normal acid secretion in H. pylori infected infants is unknown. While several recent studies have investigated changes in the gut microbiota in the first few years of life,135 the changes in gut microbiota associated with H. pylori infection in poor resource settings is unknown.

Recent experimental studies in H. pylori infected mice have shown, using ex vivo techniques to measure jejunal intestinal permeability to 51Cr-EDTA and 14C-mannitol, that small intestinal permeability is significantly increased in H. pylori infected mice compared with uninfected controls.137 Interestingly, eradication of infection in mice did not significantly improve permeability at two months post-eradication. Clinical studies indicate H. pylori infection in adults also increases intestinal permeability compared with H. pylori negative controls.138

The extent and duration of hypochlorhydria in infants and children on initial H. pylori infection may vary with the cag PAI status of the colonizing H. pylori strain as well as polymorphisms in the IL-1β gene cluster.6 In both animal models139 and symptomatic adults140,141 cag PAI strains are more likely to colonize the corpus mucosa with associated inflammation. In developed countries both increases, and changes in composition, of gastric non-H. pylori microbiota occur in H. pylori infected adults who have reduced acid secretion as a consequence of corpus atrophy, or following pharmacological treatment with proton pump inhibitors.142 Similar changes in both gastric and small intestinal microbiota during the hypochlorhydric phase following initial H. pylori infection in infants in poor resource settings are entirely possible, but remain to be investigated.

Recent exciting studies in Malawian children have identified using discordant monozigous twin pairs for kwashiorkor that the metabolism of gut microbiota and local diet are key to malnutrition.143 Gnotobiotic mice given stool samples obtained from children with kwashiorkor became malnourished on Malawian diet but changed gut microbiota and gained weight on ready-to-use therapeutic food (RUTF).143 Furthermore, a recent double blind placebo controlled study in Malawian infants aged 6 to 59 mo with kwashiorkor highlighted the importance of gut microbiota in malnutrition. Antibiotic therapy, together with RUTF, significantly reduced mortality and increased weight gain in children with malnutrition being superior to RUTF and placebo.144 These important recent studies suggest antibiotic manipulation of the gut microbiota, which contributes to malnutrition, has occurred. This raises the important question of whether antibiotics are targeting specific gut pathogens which contribute to malnutrition.145 While normal H. pylori eradication therapy requires two antibiotics and acid suppressant proton pump inhibitors,146 in H. pylori infected infants and young children with hypochlorhydria, antibiotic treatment alone would be sufficient for H. pylori eradication. At high pH the gastric mucous barrier is decreased increasing the gastric permeability of antibiotics.147 This raises the intriguing question of whether reduced mortality and weight gain following antibiotic treatment in children with malabsorption in the study of Trehan et al.144 was a consequence of H. pylori eradication, restoration of normal acid secretion and loss of small intestinal microbiota mediating permeability changes. In H. pylori positive pre-school children in Bangladeshi suppressed basal and stimulated gastric acid output is restored after successful eradication of H. pylori.51 The restoration of gastric acid secretion after eradication of H. pylori infection may result in changes to gut microbiota relevant to reduced malabsorption. Future studies should aim to address whether antibiotic treatment in children with severe malabsorption in poor resource settings is changing their H. pylori status. Recent studies have validated non-invasive diagnostic 13C urea breath tests and stool antigen assays for detection of H. pylori infection in infants in developing countries.4 This provides the necessary validated tools for non-invasively determining H. pylori status in infants in developing countries and addressing the impact of this infection on globally important potential extra-gastric manifestations of H. pylori infection in infants in developing countries.

Does H. pylori Infection in Children Impair Cognitive Function?

Gastrointestinal parasitic infections and early diarrheal disease148-150 in infancy in developing countries have been reported to impact negatively on later cognitive function in childhood and school performance in developing countries. Similarly, it has long been established that iron deficiency in infancy is associated with later impairment of cognitive function.151,152 The potential role of H. pylori infection in infancy on cognitive function has not been investigated in developing countries. Given the association of H. pylori infection with iron deficiency, as well as frequent other enteric infections and diarrheal disease in poor resource settings, investigations on direct or indirect effects of H. pylori infection on cognitive impairment would be challenging and require large longitudinal birth cohorts to be examined for cognitive function at school age.

Muhsen et al.153 have recently assessed the cognitive function of school age children in the Israeli Arab population, who have high levels of H. pylori infection although living in a developed country. Children from three villages of differing socioeconomic status were studied. H. pylori infection in children in the high socioeconomic village was independently associated with impaired cognitive function at early school age assessed by both full-scale Intelligence Quotient (IQ) score and also reduced non-verbal IQ and verbal IQ scores.153 In the low socioeconomic village an association between H. pylori infection and cognitive impairment was not observed, probably due to high levels of H. pylori infection. Further studies are required to evaluate the association of H. pylori infection with cognitive impairment particularly in developing countries. Recent longitudinal birth cohorts of infants in South America of defined H. pylori status, and with known diarrheal episodes and growth over the first two years of life4 will be valuable populations in which to analyze the contribution of H. pylori infection to cognitive function in the children at school age. The association of H. pylori with impaired cognitive function is not confined to developing country populations as H. pylori seropositivity has recently been linked with poor cognition in adults in the United States.154

Conclusions

The extra-gastric manifestations of H. pylori infection in children in developing countries are likely to be substantially greater than in developed countries and thus constitute a major public health problem. Childhood H. pylori infection in poor resource settings has been largely under investigated and further studies are required on the impact of H. pylori infection on growth impairment, diarrheal disease and cognitive impairment. Knowledge on host and bacterial factors contributing to iron deficiency in H. pylori infection in developing countries is increasing but further studies on host and bacterial polymorphisms are required in developing countries. The last Maastricht Florence Consensus Report (Maastricht IV)155 recommends treating H. pylori-positive patients with IDA after the exclusion of the other common causes of the disease. Gastric carcinoma is an important cause of death in developing countries. Recently it was demonstrated that iron deficiency accelerates H. pylori-induced gastric carcinogenesis by enhancing deployment and function of the pilus component of the cag PAI type 4 secretion system, as well as upregulating proteins involved in survival and persistence of the bacterium.156 It thus would be interesting also to consider eradication of H. pylori in those infected children without anemia, but with decreased serum ferritin. With high levels of antibiotic resistance in developing countries and significant H. pylori re-infection risk,157 the optimum future strategy will be vaccination.

Acknowledgments

DQ and JEC were funded under the Sixth Framework Programme of the European Union, Project CONTENT (INCO-DEV-3–032136), “Evaluation and Control of Neglected Mucosal Enteric Infections in Childhood”

Disclosure of Potential Conflicts of Interest

No potential conflict of interest was disclosed.

Footnotes

References

  • 1.Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther. 2002;16(Suppl 1):3–15. doi: 10.1046/j.1365-2036.2002.0160s1003.x. [DOI] [PubMed] [Google Scholar]
  • 2.Bardhan PK. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis. 1997;25:973–8. doi: 10.1086/516067. [DOI] [PubMed] [Google Scholar]
  • 3.Klein PD, Gilman RH, Leon-Barua R, Diaz F, Smith EO, Graham DY. The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol. 1994;89:2196–200. [PubMed] [Google Scholar]
  • 4.Queiroz DMM, Saito M, Rocha GA, Rocha AMC, Melo FF, Checkley W, et al. Helicobacter pylori infection in infants and toddlers in South America: concordance between 13C-urea breath test and monoclonal H. pylori stool antigen test. J Clin Microbiol. 2013 doi: 10.1128/JCM.01752-13. Forthcoming 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Windle HJ, Kelleher D, Crabtree JE. Childhood Helicobacter pylori infection and growth impairment in developing countries: a vicious cycle? Pediatrics. 2007;119:e754–9. doi: 10.1542/peds.2006-2196. [DOI] [PubMed] [Google Scholar]
  • 6.Harris PR, Serrano CA, Villagrán A, Walker MM, Thomson M, Duarte I, Windle HJ, Crabtree JE. Helicobacter pylori-associated hypochlorhydria in children, and development of iron deficiency. J Clin Pathol. 2013;66:343–7. doi: 10.1136/jclinpath-2012-201243. [DOI] [PubMed] [Google Scholar]
  • 7.Queiroz DMM, Rocha AMC, Melo FF, Rocha GA, Teixeira KN, Carvalho SD, Bittencourt PF, Castro LP, Crabtree JE. Increased gastric IL-1β concentration and iron deficiency parameters in H. pylori infected children. PLoS One. 2013;8:e57420. doi: 10.1371/journal.pone.0057420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Stoltzfus RJ. Iron-deficiency anemia: reexamining the nature and magnitude of the public health problem. Summary: implications for research and programs. J Nutr. 2001;131(2S-2):697S–700S, discussion 700S-1S. doi: 10.1093/jn/131.2.697S. [DOI] [PubMed] [Google Scholar]
  • 9.Iron deficiency anemia assessment, prevention, and control [Internet]. Geneva: WHO/UNICEF/UNU:c2001 [cited 2013 July 2]. Available from: http://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf
  • 10.Stoltzfus RJ. Iron deficiency: global prevalence and consequences. Food Nutr Bull. 2003;24(Suppl):S99–103. doi: 10.1177/15648265030244S206. [DOI] [PubMed] [Google Scholar]
  • 11.Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet. 2007;370:511–20. doi: 10.1016/S0140-6736(07)61235-5. [DOI] [PubMed] [Google Scholar]
  • 12.Casey GJ, Montresor A, Cavalli-Sforza LT, Thu H, Phu LB, Tinh TT, Tien NT, Phuc TQ, Biggs BA. Elimination of iron deficiency anemia and soil transmitted helminth infection: evidence from a fifty-four month iron-folic acid and de-worming program. PLoS Negl Trop Dis. 2013;7:e2146. doi: 10.1371/journal.pntd.0002146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Harvey LJ, Armah CN, Dainty JR, Foxall RJ, John Lewis D, Langford NJ, Fairweather-Tait SJ. Impact of menstrual blood loss and diet on iron deficiency among women in the UK. Br J Nutr. 2005;94:557–64. doi: 10.1079/BJN20051493. [DOI] [PubMed] [Google Scholar]
  • 14.Moy RJ. Prevalence, consequences and prevention of childhood nutritional iron deficiency: a child public health perspective. Clin Lab Haematol. 2006;28:291–8. doi: 10.1111/j.1365-2257.2006.00793.x. [DOI] [PubMed] [Google Scholar]
  • 15.Grantham-McGregor S, Ani C. A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr. 2001;131(2S-2):649S–66S, discussion 666S-8S. doi: 10.1093/jn/131.2.649S. [DOI] [PubMed] [Google Scholar]
  • 16.Stoltzfus RJ, Kvalsvig JD, Chwaya HM, Montresor A, Albonico M, Tielsch JM, Savioli L, Pollitt E. Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study. BMJ. 2001;323:1389–93. doi: 10.1136/bmj.323.7326.1389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Idjradinata P, Pollitt E. Reversal of developmental delays in iron-deficient anaemic infants treated with iron. Lancet. 1993;341:1–4. doi: 10.1016/0140-6736(93)92477-B. [DOI] [PubMed] [Google Scholar]
  • 18.Blecker U, Renders F, Lanciers S, Vandenplas Y. Syncopes leading to the diagnosis of a Helicobacter pylori positive chronic active haemorrhagic gastritis. Eur J Pediatr. 1991;150:560–1. doi: 10.1007/BF02072207. [DOI] [PubMed] [Google Scholar]
  • 19.Dufour C, Brisigotti M, Fabretti G, Luxardo P, Mori PG, Barabino A. Helicobacter pylori gastric infection and sideropenic refractory anemia. J Pediatr Gastroenterol Nutr. 1993;17:225–7. doi: 10.1097/00005176-199308000-00018. [DOI] [PubMed] [Google Scholar]
  • 20.Carnicer J, Badía R, Argemí J. Helicobacter pylori gastritis and sideropenic refractory anemia. J Pediatr Gastroenterol Nutr. 1997;25:441. doi: 10.1097/00005176-199710000-00017. [DOI] [PubMed] [Google Scholar]
  • 21.Kostaki M, Fessatou S, Karpathios T. Refractory iron-deficiency anaemia due to silent Helicobacter pylori gastritis in children. Eur J Pediatr. 2003;162:177–9. doi: 10.1007/s00431-002-1139-x. [DOI] [PubMed] [Google Scholar]
  • 22.Russo-Mancuso G, Branciforte F, Licciardello M, La Spina M. Iron deficiency anemia as the only sign of infection with Helicobacter pylori: a report of 9 pediatric cases. Int J Hematol. 2003;78:429–31. doi: 10.1007/BF02983815. [DOI] [PubMed] [Google Scholar]
  • 23.Choe YH, Kim SK, Hong YC. The relationship between Helicobacter pylori infection and iron deficiency: seroprevalence study in 937 pubescent children. Arch Dis Child. 2003;88:178. doi: 10.1136/adc.88.2.178-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yang YJ, Sheu BS, Lee SC, Yang HB, Wu JJ. Children of Helicobacter pylori-infected dyspeptic mothers are predisposed to H. pylori acquisition with subsequent iron deficiency and growth retardation. Helicobacter. 2005;10:249–55. doi: 10.1111/j.1523-5378.2005.00317.x. [DOI] [PubMed] [Google Scholar]
  • 25.Baggett HC, Parkinson AJ, Muth PT, Gold BD, Gessner BD. Endemic iron deficiency associated with Helicobacter pylori infection among school-aged children in Alaska. Pediatrics. 2006;117:e396–404. doi: 10.1542/peds.2005-1129. [DOI] [PubMed] [Google Scholar]
  • 26.Cardenas VM, Mulla ZD, Ortiz M, Graham DY. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol. 2006;163:127–34. doi: 10.1093/aje/kwj018. [DOI] [PubMed] [Google Scholar]
  • 27.Muhsen K, Barak M, Henig C, Alpert G, Ornoy A, Cohen D. Is the association between Helicobacter pylori infection and anemia age dependent? Helicobacter. 2010;15:467–72. doi: 10.1111/j.1523-5378.2010.00793.x. [DOI] [PubMed] [Google Scholar]
  • 28.Afifi RAR, Ali DK, Shaheen IAM. A localized case-control study of extra-gastric manifestations of Helicobacter pylori infection in children. Indian J Pediatr. 2011;78:418–22. doi: 10.1007/s12098-010-0308-6. [DOI] [PubMed] [Google Scholar]
  • 29.Parkinson AJ, Gold BD, Bulkow L, Wainwright RB, Swaminathan B, Khanna B, Petersen KM, Fitzgerald MA. High prevalence of Helicobacter pylori in the Alaska native population and association with low serum ferritin levels in young adults. Clin Diagn Lab Immunol. 2000;7:885–8. doi: 10.1128/cdli.7.6.885-888.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Queiroz DMM, Harris PR, Sanderson IR, Windle HJ, Walker MM, Rocha AMC, Rocha GA, Carvalho SD, Bittencourt PF, de Castro LP, et al. Iron status and Helicobacter pylori infection in symptomatic children: an international multi-centered study. PLoS One. 2013;8:e68833. doi: 10.1371/journal.pone.0068833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Süoglu OD, Gökçe S, Saglam AT, Sökücü S, Saner G. Association of Helicobacter pylori infection with gastroduodenal disease, epidemiologic factors and iron-deficiency anemia in Turkish children undergoing endoscopy, and impact on growth. Pediatr Int. 2007;49:858–63. doi: 10.1111/j.1442-200X.2007.02444.x. [DOI] [PubMed] [Google Scholar]
  • 32.Choi JW. Does Helicobacter pylori infection relate to iron deficiency anaemia in prepubescent children under 12 years of age? Acta Paediatr. 2003;92:970–2. doi: 10.1111/j.1651-2227.2003.tb00633.x. [DOI] [PubMed] [Google Scholar]
  • 33.Araf LN, Pereira CAB, Machado RS, Raguza D, Kawakami E. Helicobacter pylori and iron-deficiency anemia in adolescents in Brazil. J Pediatr Gastroenterol Nutr. 2010;51:477–80. doi: 10.1097/MPG.0b013e3181d40cd7. [DOI] [PubMed] [Google Scholar]
  • 34.Janjetic MA, Goldman CG, Balcarce NE, Rua EC, González AB, Fuda JA, Meseri EI, Torti HE, Barrado J, Zubillaga MB, et al. Iron, zinc, and copper nutritional status in children infected with Helicobacter pylori. J Pediatr Gastroenterol Nutr. 2010;51:85–9. doi: 10.1097/MPG.0b013e3181c2c2cd. [DOI] [PubMed] [Google Scholar]
  • 35.Vendt N, Kool P, Teesalu K, Lillemäe K, Maaroos HI, Oona M. Iron deficiency and Helicobacter pylori infection in children. Acta Paediatr. 2011;100:1239–43. doi: 10.1111/j.1651-2227.2011.02281.x. [DOI] [PubMed] [Google Scholar]
  • 36.Akcam M, Ozdem S, Yilmaz A, Gultekin M, Artan R. Serum ferritin, vitamin B(12), folate, and zinc levels in children infected with Helicobacter pylori. Dig Dis Sci. 2007;52:405–10. doi: 10.1007/s10620-006-9422-8. [DOI] [PubMed] [Google Scholar]
  • 37.de Oliveira AM, Rocha GA, Queiroz DMM, Mendes EN, de Carvalho AS, Ferrari TC, Nogueira AM. Evaluation of enzyme-linked immunosorbent assay for the diagnosis of Helicobacter pylori infection in children from different age groups with and without duodenal ulcer. J Pediatr Gastroenterol Nutr. 1999;28:157–61. doi: 10.1097/00005176-199902000-00012. [DOI] [PubMed] [Google Scholar]
  • 38.Choe YH, Kim SK, Son BK, Lee DH, Hong YC, Pai SH. Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents. Helicobacter. 1999;4:135–9. doi: 10.1046/j.1523-5378.1999.98066.x. [DOI] [PubMed] [Google Scholar]
  • 39.Choe YH, Lee JE, Kim SK. Effect of helicobacter pylori eradication on sideropenic refractory anaemia in adolescent girls with Helicobacter pylori infection. Acta Paediatr. 2000;89:154–7. doi: 10.1111/j.1651-2227.2000.tb01208.x. [DOI] [PubMed] [Google Scholar]
  • 40.Choe YH, Kwon YS, Jung MK, Kang SK, Hwang TS, Hong YC. Helicobacter pylori-associated iron-deficiency anemia in adolescent female athletes. J Pediatr. 2001;139:100–4. doi: 10.1067/mpd.2001.114700. [DOI] [PubMed] [Google Scholar]
  • 41.Kurekci AE, Atay AA, Sarici SU, Yesilkaya E, Senses Z, Okutan V, Ozcan O. Is there a relationship between childhood Helicobacter pylori infection and iron deficiency anemia? J Trop Pediatr. 2005;51:166–9. doi: 10.1093/tropej/fmi015. [DOI] [PubMed] [Google Scholar]
  • 42.Fagan RP, Dunaway CE, Bruden DL, Parkinson AJ, Gessner BD. Controlled, household-randomized, open-label trial of the effect of treatment of Helicobacter pylori infection on iron deficiency among children in rural Alaska: results at 40 months. J Infect Dis. 2009;199:652–60. doi: 10.1086/596659. [DOI] [PubMed] [Google Scholar]
  • 43.Duque X, Moran S, Mera R, Medina M, Martinez H, Mendoza ME, Torres J, Correa P. Effect of eradication of Helicobacter pylori and iron supplementation on the iron status of children with iron deficiency. Arch Med Res. 2010;41:38–45. doi: 10.1016/j.arcmed.2009.11.006. [DOI] [PubMed] [Google Scholar]
  • 44.Xia W, Zhang X, Wang J, Sun C, Wu L. Survey of anaemia and Helicobacter pylori infection in adolescent girls in Suihua, China and enhancement of iron intervention effects by H. pylori eradication. Br J Nutr. 2012;108:357–62. doi: 10.1017/S0007114511005666. [DOI] [PubMed] [Google Scholar]
  • 45.Cardenas VM, Prieto-Jimenez CA, Mulla ZD, Rivera JO, Dominguez DC, Graham DY, Ortiz M. Helicobacter pylori eradication and change in markers of iron stores among non-iron-deficient children in El Paso, Texas: an etiologic intervention study. J Pediatr Gastroenterol Nutr. 2011;52:326–32. doi: 10.1097/MPG.0b013e3182054123. [DOI] [PubMed] [Google Scholar]
  • 46.Sarker SA, Mahmud H, Davidsson L, Alam NH, Ahmed T, Alam N, Salam MA, Beglinger C, Gyr N, Fuchs GJ. Causal relationship of Helicobacter pylori with iron-deficiency anemia or failure of iron supplementation in children. Gastroenterology. 2008;135:1534–42. doi: 10.1053/j.gastro.2008.07.030. [DOI] [PubMed] [Google Scholar]
  • 47.Yuan W, Li Yumin, Yang Kehu, Ma Bin, Guan Quanlin, Wang D, Yang L. Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2010;45:665–76. doi: 10.3109/00365521003663670. [DOI] [PubMed] [Google Scholar]
  • 48.Huang X, Qu X, Yan W, Huang Y, Cai M, Hu B, Wu L, Lin H, Chen Z, Zhu C, et al. Iron deficiency anaemia can be improved after eradication of Helicobacter pylori. Postgrad Med J. 2010;86:272–8. doi: 10.1136/pgmj.2009.089987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Gwamaka M, Kurtis JD, Sorensen BE, Holte S, Morrison R, Mutabingwa TK, Fried M, Duffy PE. Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children. Clin Infect Dis. 2012;54:1137–44. doi: 10.1093/cid/cis010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Annibale B, Capurso G, Delle Fave G. The stomach and iron deficiency anaemia: a forgotten link. Dig Liver Dis. 2003;35:288–95. doi: 10.1016/S1590-8658(03)00067-7. [DOI] [PubMed] [Google Scholar]
  • 51.Sarker SA, Davidsson L, Mahmud H, Walczyk T, Hurrell RF, Gyr N, Fuchs GJ. Helicobacter pylori infection, iron absorption, and gastric acid secretion in Bangladeshi children. Am J Clin Nutr. 2004;80:149–53. doi: 10.1093/ajcn/80.1.149. [DOI] [PubMed] [Google Scholar]
  • 52.Sobala GM, Crabtree JE, Dixon MF, Schorah CJ, Taylor JD, Rathbone BJ, Heatley RV, Axon AT. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut. 1991;32:1415–8. doi: 10.1136/gut.32.11.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Harford WV, Barnett C, Lee E, Perez-Perez G, Blaser MJ, Peterson WL. Acute gastritis with hypochlorhydria: report of 35 cases with long term follow up. Gut. 2000;47:467–72. doi: 10.1136/gut.47.4.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology. 2007;133:288–308. doi: 10.1053/j.gastro.2007.05.008. [DOI] [PubMed] [Google Scholar]
  • 55.Beales IL, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut. 1998;42:227–34. doi: 10.1136/gut.42.2.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut. 1991;32:1473–7. doi: 10.1136/gut.32.12.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398–402. doi: 10.1038/35006081. [DOI] [PubMed] [Google Scholar]
  • 58.Freire de Melo F, Rocha AMC, Rocha GA, Pedroso SHSP, de Assis Batista S, Fonseca de Castro LP, Carvalho SD, Bittencourt PF, de Oliveira CA, Corrêa-Oliveira R, et al. A regulatory instead of an IL-17 T response predominates in Helicobacter pylori-associated gastritis in children. Microbes Infect. 2012;14:341–7. doi: 10.1016/j.micinf.2011.11.008. [DOI] [PubMed] [Google Scholar]
  • 59.Fox JG, Otto G, Taylor NS, Rosenblad W, Murphy JC. Helicobacter mustelae-induced gastritis and elevated gastric pH in the ferret (Mustela putorius furo) Infect Immun. 1991;59:1875–80. doi: 10.1128/iai.59.6.1875-1880.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Takashima M, Furuta T, Hanai H, Sugimura H, Kaneko E. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut. 2001;48:765–73. doi: 10.1136/gut.48.6.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Graham DY, Opekun AR, Osato MS, El-Zimaity HMT, Lee CK, Yamaoka Y, Qureshi WA, Cadoz M, Monath TP. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004;53:1235–43. doi: 10.1136/gut.2003.037499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Thomas JE, Eastham EJ, Weaver LT. New non-invasive test of gastric acid secretion for use in children. Gut. 1993;34:738–41. doi: 10.1136/gut.34.6.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Dale A, Thomas JE, Darboe MK, Coward WA, Harding M, Weaver LT. Helicobacter pylori infection, gastric acid secretion, and infant growth. J Pediatr Gastroenterol Nutr. 1998;26:393–7. doi: 10.1097/00005176-199804000-00006. [DOI] [PubMed] [Google Scholar]
  • 64.Inamura J, Ikuta K, Jimbo J, Shindo M, Sato K, Torimoto Y, Kohgo Y. Upregulation of hepcidin by interleukin-1β in human hepatoma cell lines. Hepatol Res. 2005;33:198–205. doi: 10.1016/j.hepres.2005.08.005. [DOI] [PubMed] [Google Scholar]
  • 65.Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A. 2005;102:1906–10. doi: 10.1073/pnas.0409808102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Schwarz P, Kübler JAM, Strnad P, Müller K, Barth TFE, Gerloff A, Feick P, Peyssonnaux C, Vaulont S, Adler G, et al. Hepcidin is localised in gastric parietal cells, regulates acid secretion and is induced by Helicobacter pylori infection. Gut. 2012;61:193–201. doi: 10.1136/gut.2011.241208. [DOI] [PubMed] [Google Scholar]
  • 67.Annibale B, Capurso G, Lahner E, Passi S, Ricci R, Maggio F, Delle Fave G. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut. 2003;52:496–501. doi: 10.1136/gut.52.4.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Nahon S, Lahmek P, Massard J, Lesgourgues B, Mariaud de Serre N, Traissac L, Bodiguel V, Adotti F, Delas N. Helicobacter pylori-associated chronic gastritis and unexplained iron deficiency anemia: a reliable association? Helicobacter. 2003;8:573–7. doi: 10.1111/j.1523-5378.2003.00184.x. [DOI] [PubMed] [Google Scholar]
  • 69.Baysoy G, Ertem D, Ademoğlu E, Kotiloğlu E, Keskin S, Pehlivanoğlu E. Gastric histopathology, iron status and iron deficiency anemia in children with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2004;38:146–51. doi: 10.1097/00005176-200402000-00008. [DOI] [PubMed] [Google Scholar]
  • 70.Capurso G, Lahner E, Marcheggiano A, Caruana P, Carnuccio A, Bordi C, Delle Fave G, Annibale B. Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anaemia associated with Helicobacter pylori infection. Aliment Pharmacol Ther. 2001;15:1753–61. doi: 10.1046/j.1365-2036.2001.01101.x. [DOI] [PubMed] [Google Scholar]
  • 71.Doig P, Austin JW, Trust TJ. The Helicobacter pylori 19.6-kilodalton protein is an iron-containing protein resembling ferritin. J Bacteriol. 1993;175:557–60. doi: 10.1128/jb.175.2.557-560.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Worst DJ, Otto BR, de Graaff J. Iron-repressible outer membrane proteins of Helicobacter pylori involved in heme uptake. Infect Immun. 1995;63:4161–5. doi: 10.1128/iai.63.10.4161-4165.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Dhaenens L, Szczebara F, Husson MO. Identification, characterization, and immunogenicity of the lactoferrin-binding protein from Helicobacter pylori. Infect Immun. 1997;65:514–8. doi: 10.1128/iai.65.2.514-518.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Tonello F, Dundon WG, Satin B, Molinari M, Tognon G, Grandi G, Del Giudice G, Rappuoli R, Montecucco C. The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure. Mol Microbiol. 1999;34:238–46. doi: 10.1046/j.1365-2958.1999.01584.x. [DOI] [PubMed] [Google Scholar]
  • 75.Velayudhan J, Hughes NJ, McColm AA, Bagshaw J, Clayton CL, Andrews SC, Kelly DJ. Iron acquisition and virulence in Helicobacter pylori: a major role for FeoB, a high-affinity ferrous iron transporter. Mol Microbiol. 2000;37:274–86. doi: 10.1046/j.1365-2958.2000.01987.x. [DOI] [PubMed] [Google Scholar]
  • 76.Ge R, Sun X. Iron trafficking system in Helicobacter pylori. Biometals. 2012;25:247–58. doi: 10.1007/s10534-011-9512-8. [DOI] [PubMed] [Google Scholar]
  • 77.van Vliet AHM, Stoof J, Vlasblom R, Wainwright SA, Hughes NJ, Kelly DJ, Bereswill S, Bijlsma JJ, Hoogenboezem T, Vandenbroucke-Grauls CM, et al. The role of the Ferric Uptake Regulator (Fur) in regulation of Helicobacter pylori iron uptake. Helicobacter. 2002;7:237–44. doi: 10.1046/j.1523-5378.2002.00088.x. [DOI] [PubMed] [Google Scholar]
  • 78.González-López MA, Olivares-Trejo JJ. The gene frpB2 of Helicobacter pylori encodes an hemoglobin-binding protein involved in iron acquisition. Biometals. 2009;22:889–94. doi: 10.1007/s10534-009-9240-5. [DOI] [PubMed] [Google Scholar]
  • 79.Lee JH, Choe YH, Choi YO. The expression of iron-repressible outer membrane proteins in Helicobacter pylori and its association with iron deficiency anemia. Helicobacter. 2009;14:36–9. doi: 10.1111/j.1523-5378.2009.00658.x. [DOI] [PubMed] [Google Scholar]
  • 80.Senkovich O, Ceaser S, McGee DJ, Testerman TL. Unique host iron utilization mechanisms of Helicobacter pylori revealed with iron-deficient chemically defined media. Infect Immun. 2010;78:1841–9. doi: 10.1128/IAI.01258-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Tan S, Noto JM, Romero-Gallo J, Peek RM, Jr., Amieva MR. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog. 2011;7:e1002050. doi: 10.1371/journal.ppat.1002050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Yokota S, Konno M, Mino E, Sato K, Takahashi M, Fujii N. Enhanced Fe ion-uptake activity in Helicobacter pylori strains isolated from patients with iron-deficiency anemia. Clin Infect Dis. 2008;46:e31–3. doi: 10.1086/526784. [DOI] [PubMed] [Google Scholar]
  • 83.Park SA, Lee HW, Hong MH, Choi YW, Choe YH, Ahn BY, Cho YJ, Kim DS, Lee NG. Comparative proteomic analysis of Helicobacter pylori strains associated with iron deficiency anemia. Proteomics. 2006;6:1319–28. doi: 10.1002/pmic.200500293. [DOI] [PubMed] [Google Scholar]
  • 84.Yokota S, Toita N, Yamamoto S, Fujii N, Konno M. Positive relationship between a polymorphism in Helicobacter pylori neutrophil-activating protein a gene and iron-deficiency anemia. Helicobacter. 2013;18:112–6. doi: 10.1111/hel.12011. [DOI] [PubMed] [Google Scholar]
  • 85.Hee MH, Choe YH, Cho YJ, Ahn BY, Lee NG. Sequencing and comparative analysis of napA genes from Helicobacter pylori strains associated with iron-deficiency anemia. J Microbiol Biotechnol. 2005;15:866–72. [Google Scholar]
  • 86.Jeon BH, Oh YJ, Lee NG, Choe YH. Polymorphism of the Helicobacter pylori feoB gene in Korea: a possible relation with iron-deficiency anemia? Helicobacter. 2004;9:330–4. doi: 10.1111/j.1083-4389.2004.00239.x. [DOI] [PubMed] [Google Scholar]
  • 87.Choe YH, Hwang TS, Kim HJ, Shin SH, Song SU, Choi MS. A possible relation of the Helicobacter pylori pfr gene to iron deficiency anemia? Helicobacter. 2001;6:55–9. doi: 10.1046/j.1523-5378.2001.00007.x. [DOI] [PubMed] [Google Scholar]
  • 88.Choe YH, Oh YJ, Lee NG, Imoto I, Adachi Y, Toyoda N, Gabazza EC. Lactoferrin sequestration and its contribution to iron-deficiency anemia in Helicobacter pylori-infected gastric mucosa. J Gastroenterol Hepatol. 2003;18:980–5. doi: 10.1046/j.1440-1746.2003.03098.x. [DOI] [PubMed] [Google Scholar]
  • 89.Howden CW, Hunt RH. Relationship between gastric secretion and infection. Gut. 1987;28:96–107. doi: 10.1136/gut.28.1.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Martinsen TC, Bergh K, Waldum HL. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol. 2005;96:94–102. doi: 10.1111/j.1742-7843.2005.pto960202.x. [DOI] [PubMed] [Google Scholar]
  • 91.Lin J, Lee IS, Frey J, Slonczewski JL, Foster JW. Comparative analysis of extreme acid survival in Salmonella typhimurium, Shigella flexneri, and Escherichia coli. J Bacteriol. 1995;177:4097–104. doi: 10.1128/jb.177.14.4097-4104.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Evans CA, Gilman RH, Rabbani GH, Salazar G, Ali A. Gastric acid secretion and enteric infection in Bangladesh. Trans R Soc Trop Med Hyg. 1997;91:681–5. doi: 10.1016/S0035-9203(97)90523-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Khosla SN, Jain N, Khosla A. Gastric acid secretion in typhoid fever. Postgrad Med J. 1993;69:121–3. doi: 10.1136/pgmj.69.808.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Weiss C, Clark HF. Rapid inactivation of rotaviruses by exposure to acid buffer or acidic gastric juice. J Gen Virol. 1985;66:2725–30. doi: 10.1099/0022-1317-66-12-2725. [DOI] [PubMed] [Google Scholar]
  • 95.Yearsley KA, Gilby LJ, Ramadas AV, Kubiak EM, Fone DL, Allison MC. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Aliment Pharmacol Ther. 2006;24:613–9. doi: 10.1111/j.1365-2036.2006.03015.x. [DOI] [PubMed] [Google Scholar]
  • 96.Sullivan PB, Thomas JE, Wight DGD, Neale G, Eastham EJ, Corrah T, Lloyd-Evans N, Greenwood BM. Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition. Arch Dis Child. 1990;65:189–91. doi: 10.1136/adc.65.2.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Passaro DJ, Taylor DN, Meza R, Cabrera L, Gilman RH, Parsonnet J. Acute Helicobacter pylori infection is followed by an increase in diarrheal disease among Peruvian children. Pediatrics. 2001;108:E87. doi: 10.1542/peds.108.5.e87. [DOI] [PubMed] [Google Scholar]
  • 98.Shahinian ML, Passaro DJ, Swerdlow DL, Mintz ED, Rodriguez M, Parsonnet J. Helicobacter pylori and epidemic Vibrio cholerae 01 infection in Peru. Lancet. 2000;335:377–8. doi: 10.1016/S0140-6736(99)05143-0. [DOI] [PubMed] [Google Scholar]
  • 99.León-Barúa R, Recavarren-Arce S, Chinga-Alayo E, Rodríguez-Ulloa C, Taylor DN, Gotuzzo E, Kosek M, Eza D, Gilman RH. Helicobacter pylori-associated chronic atrophic gastritis involving the gastric body and severe disease by Vibrio cholerae. Trans R Soc Trop Med Hyg. 2006;100:567–72. doi: 10.1016/j.trstmh.2005.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Clemens J, Albert MJ, Rao M, Qadri F, Huda S, Kay B, van Loon FP, Sack D, Pradhan BA, Sack RB. Impact of infection by Helicobacter pylori on the risk and severity of endemic cholera. J Infect Dis. 1995;171:1653–6. doi: 10.1093/infdis/171.6.1653. [DOI] [PubMed] [Google Scholar]
  • 101.Shmuely H, Samra Z, Ashkenazi S, Dinari G, Chodick G, Yahav J. Association of Helicobacter pylori infection with Shigella gastroenteritis in young children. Am J Gastroenterol. 2004;99:2041–5. doi: 10.1111/j.1572-0241.2004.40120.x. [DOI] [PubMed] [Google Scholar]
  • 102.Vollaard AM, Verspaget HW, Ali S, Visser LG, Veenendaal RA, Van Asten HA, Widjaja S, Surjadi Ch, Van Dissel JT. Helicobacter pylori infection and typhoid fever in Jakarta, Indonesia. Epidemiol Infect. 2006;134:163–70. doi: 10.1017/S0950268805004875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Isenbarger DW, Bodhidatta L, Hoge CW, Nirdnoy W, Pitarangsi C, Umpawasiri U, Echeverria P. Prospective study of the incidence of diarrheal disease and Helicobacter pylori infection among children in an orphanage in Thailand. Am J Trop Med Hyg. 1998;59:796–800. doi: 10.4269/ajtmh.1998.59.796. [DOI] [PubMed] [Google Scholar]
  • 104.Perry S, Sanchez L, Yang S, Haggerty TD, Hurst P, Parsonnet J. Helicobacter pylori and risk of gastroenteritis. J Infect Dis. 2004;190:303–10. doi: 10.1086/421705. [DOI] [PubMed] [Google Scholar]
  • 105.Rothenbacher D, Blaser MJ, Bode G, Brenner H. Inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study. J Infect Dis. 2000;182:1446–9. doi: 10.1086/315887. [DOI] [PubMed] [Google Scholar]
  • 106.Perri F, Pastore M, Leandro G, Clemente R, Ghoos Y, Peeters M, Annese V, Quitadamo M, Latiano A, Rutgeerts P, et al. Helicobacter pylori infection and growth delay in older children. Arch Dis Child. 1997;77:46–9. doi: 10.1136/adc.77.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Richter T, Richter T, List S, Müller DM, Deutscher J, Uhlig HH, Krumbiegel P, Herbarth O, Gutsmuths FJ, Kiess W. Five- to 7-year-old children with Helicobacter pylori infection are smaller than Helicobacter-negative children: a cross-sectional population-based study of 3,315 children. J Pediatr Gastroenterol Nutr. 2001;33:472–5. doi: 10.1097/00005176-200110000-00010. [DOI] [PubMed] [Google Scholar]
  • 108.Ertem D, Pehlivanoglu E. Helicobacter pylori may influence height in children independent of socioeconomic factors. J Pediatr Gastroenterol Nutr. 2002;35:232–3. doi: 10.1097/00005176-200208000-00028. [DOI] [PubMed] [Google Scholar]
  • 109.Takahashi M, Kimura H, Watanabe K. Helicobacter pylori infection in patients with idiopathic short stature. Pediatr Int. 2002;44:277–80. doi: 10.1046/j.1442-200X.2002.01557.x. [DOI] [PubMed] [Google Scholar]
  • 110.Fialho AMN, Braga ABC, Queiroz DMM, Rodrigues MN, Herbster ID, Braga LLBC. The association between Helicobacter pylori infection and height in children from an urban community in north-east Brazil. Ann Trop Paediatr. 2007;27:55–61. doi: 10.1179/146532807X170510. [DOI] [PubMed] [Google Scholar]
  • 111.Mohammad MA, Hussein L, Coward A, Jackson SJ. Prevalence of Helicobacter pylori infection among Egyptian children: impact of social background and effect on growth. Public Health Nutr. 2008;11:230–6. doi: 10.1017/S1368980007000481. [DOI] [PubMed] [Google Scholar]
  • 112.Vilchis J, Duque X, Mera R, Morán S, Torres J, González-Cossío T, Kageyama-Escobar MdeL, Navarro F, Mendoza ME, Correa P. Association of Helicobacter pylori infection and height of Mexican children of low socioeconomic level attending boarding schools. Am J Trop Med Hyg. 2009;81:1091–6. doi: 10.4269/ajtmh.2009.09-0107. [DOI] [PubMed] [Google Scholar]
  • 113.Ozen A, Furman A, Berber M, Karatepe HO, Mutlu N, Sarıçoban HE, Büyükgebiz B. The effect of Helicobacter pylori and economic status on growth parameters and leptin, ghrelin, and insulin-like growth factor (IGF)-I concentrations in children. Helicobacter. 2011;16:55–65. doi: 10.1111/j.1523-5378.2010.00814.x. [DOI] [PubMed] [Google Scholar]
  • 114.Oderda G, Palli D, Saieva C, Chiorboli E, Bona G. Short stature and Helicobacter pylori infection in italian children: prospective multicentre hospital based case-control study. The Italian Study Group on Short Stature and H pylori. BMJ. 1998;317:514–5. doi: 10.1136/bmj.317.7157.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Vaira D, Menegatti M, Salardi S, Alì A, Altomare Stella F, Figura N, Landi F, Holton J, Farinelli S, Cuccaro V, et al. Helicobacter pylori and diminished growth in children: is it simply a marker of deprivation? Ital J Gastroenterol Hepatol. 1998;30:129–33. [PubMed] [Google Scholar]
  • 116.Quiñonez JM, Chew F, Torres O, Bégué RE. Nutritional status of Helicobacter pylori-infected children in Guatemala as compared with uninfected peers. Am J Trop Med Hyg. 1999;61:395–8. doi: 10.4269/ajtmh.1999.61.395. [DOI] [PubMed] [Google Scholar]
  • 117.Ozçay F, Demir H, Özen H, Gürakan F, Saltik IN, Yüce A, Koçak N. Normal growth in young children with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2002;35:102. doi: 10.1097/00005176-200207000-00024. [DOI] [PubMed] [Google Scholar]
  • 118.Chimonas MAR, Baggett HC, Parkinson AJ, Muth PT, Dunaway E, Gessner BD. Asymptomatic Helicobacter pylori infection and iron deficiency are not associated with decreased growth among Alaska Native children aged 7-11 years. Helicobacter. 2006;11:159–67. doi: 10.1111/j.1523-5378.2006.00395.x. [DOI] [PubMed] [Google Scholar]
  • 119.Soylu ÖB, Ozturk Y. Helicobacter pylori infection: effect on malnutrition and growth failure in dyspeptic children. Eur J Pediatr. 2008;167:557–62. doi: 10.1007/s00431-007-0552-6. [DOI] [PubMed] [Google Scholar]
  • 120.Cherian S, Forbes D, Sanfilippo F, Cook A, Burgner D. Helicobacter pylori, helminth infections and growth: a cross-sectional study in a high prevalence population. Acta Paediatr. 2009;98:860–4. doi: 10.1111/j.1651-2227.2009.01221.x. [DOI] [PubMed] [Google Scholar]
  • 121.Dehghani SM, Karamifar H, Raeesi T, Haghighat M. Growth parameters in children with dyspepsia symptoms and Helicobacter pylori infection. Indian Pediatr. 2013;50:324–6. doi: 10.1007/s13312-013-0090-4. [DOI] [PubMed] [Google Scholar]
  • 122.Choe YH, Kim SK, Hong YC. Helicobacter pylori infection with iron deficiency anaemia and subnormal growth at puberty. Arch Dis Child. 2000;82:136–40. doi: 10.1136/adc.82.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Gulcan M, Ozen A, Karatepe HO, Gulcu D, Vitrinel A. Impact of H. pylori on growth: is the infection or mucosal disease related to growth impairment? Dig Dis Sci. 2010;55:2878–86. doi: 10.1007/s10620-009-1091-y. [DOI] [PubMed] [Google Scholar]
  • 124.Goodman KJ, Correa P, Mera R, Yepez MC, Cerón C, Campo C, Guerrero N, Sierra MS, Bravo LE. Effect of Helicobacter pylori infection on growth velocity of school-age Andean children. Epidemiology. 2011;22:118–26. doi: 10.1097/EDE.0b013e3181fe7e31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Patel P, Mendall MA, Khulusi S, Northfield TC, Strachan DP. Helicobacter pylori infection in childhood: risk factors and effect on growth. BMJ. 1994;309:1119–23. doi: 10.1136/bmj.309.6962.1119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Bravo LE, Mera R, Reina JC, Pradilla A, Alzate A, Fontham E, Correa P. Impact of Helicobacter pylori infection on growth of children: a prospective cohort study. J Pediatr Gastroenterol Nutr. 2003;37:614–9. doi: 10.1097/00005176-200311000-00021. [DOI] [PubMed] [Google Scholar]
  • 127.Thomas JE, Dale A, Bunn JEG, Harding M, Coward WA, Cole TJ, Weaver LT. Early Helicobacter pylori colonisation: the association with growth faltering in The Gambia. Arch Dis Child. 2004;89:1149–54. doi: 10.1136/adc.2002.015313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Egorov AI, Sempértegui F, Estrella B, Egas J, Naumova EN, Griffiths JK. The effect of Helicobacter pylori infection on growth velocity in young children from poor urban communities in Ecuador. Int J Infect Dis. 2010;14:e788–91. doi: 10.1016/j.ijid.2010.03.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Mera RM, Bravo LE, Goodman KJ, Yepez MC, Correa P. Long-term effects of clearing Helicobacter pylori on growth in school-age children. Pediatr Infect Dis J. 2012;31:263–6. doi: 10.1097/INF.0b013e3182443fec. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Yang YJ, Sheu BS, Yang HB, Lu CC, Chuang CC. Eradication of Helicobacter pylori increases childhood growth and serum acylated ghrelin levels. World J Gastroenterol. 2012;18:2674–81. doi: 10.3748/wjg.v18.i21.2674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Sood MR, Joshi S, Akobeng AK, Mitchell J, Thomas AG. Growth in children with Helicobacter pylori infection and dyspepsia. Arch Dis Child. 2005;90:1025–8. doi: 10.1136/adc.2004.066803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Mera RM, Correa P, Fontham EE, Reina JC, Pradilla A, Alzate A, Bravo LE. Effects of a new Helicobacter pylori infection on height and weight in Colombian children. Ann Epidemiol. 2006;16:347–51. doi: 10.1016/j.annepidem.2005.08.002. [DOI] [PubMed] [Google Scholar]
  • 133.Sawczenko A, Azooz O, Paraszczuk J, Idestrom M, Croft NM, Savage MO, Ballinger AB, Sanderson IR. Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci U S A. 2005;102:13260–5. doi: 10.1073/pnas.0503589102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Lunn PG, Northrop-Clewes CA, Downes RM. Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet. 1991;338:907–10. doi: 10.1016/0140-6736(91)91772-M. [DOI] [PubMed] [Google Scholar]
  • 135.Gordon JI, Dewey KG, Mills DA, Medzhitov RM. The human gut microbiota and undernutrition. Sci Transl Med. 2012;4:37ps12. doi: 10.1126/scitranslmed.3004347. [DOI] [PubMed] [Google Scholar]
  • 136.Guerrant RL, DeBoer M. D., Moore SR, Scharf RJ, Lima A.A.M. The impoverished gut- a triple burden of diarrhoea, stunting and chronic disease. Nature Rev Gastroenterol Hepatol. 2013;10:220–9. doi: 10.1038/nrgastro.2012.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Verdu EF, Bercik P, Huang XX, Lu J, Al-Mutawaly N, Sakai H, Tompkins TA, Croitoru K, Tsuchida E, Perdue M, et al. The role of luminal factors in the recovery of gastric function and behavioral changes after chronic Helicobacter pylori infection. Am J Physiol Gastrointest Liver Physiol. 2008;295:G664–70. doi: 10.1152/ajpgi.90316.2008. [DOI] [PubMed] [Google Scholar]
  • 138.Di Leo V, D’Inca R, Bettini MB, Podswiadek M, Punzi L, Mastropaolo G, Sturniolo GC. Effect of Helicobacter pylori and eradication therapy on gastrointestinal permeability. Implications for patients with seronegative spondyloarthritis. J Rheumatol. 2005;32:295–300. [PubMed] [Google Scholar]
  • 139.Rieder G, Merchant JL, Haas R. Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology. 2005;128:1229–42. doi: 10.1053/j.gastro.2005.02.064. [DOI] [PubMed] [Google Scholar]
  • 140.Shimoyama T, Everett SM, Dixon MF, Axon ATR, Crabtree JE. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol. 1998;51:765–70. doi: 10.1136/jcp.51.10.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Peek RM, Jr., Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol. 2006;208:233–48. doi: 10.1002/path.1868. [DOI] [PubMed] [Google Scholar]
  • 142.Engstrand L, Lindberg M. Helicobacter pylori and the gastric microbiota. Best Pract Res Clin Gastroenterol. 2013;27:39–45. doi: 10.1016/j.bpg.2013.03.016. [DOI] [PubMed] [Google Scholar]
  • 143.Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J, Kau AL, Rich SS, Concannon P, Mychaleckyj JC, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science. 2013;339:548–54. doi: 10.1126/science.1229000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Trehan I, Goldbach HS, LaGrone LN, Meuli GJ, Wang RJ, Maleta KM, Manary MJ. Antibiotics as part of the management of severe acute malnutrition. N Engl J Med. 2013;368:425–35. doi: 10.1056/NEJMoa1202851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Tilg H, Moschen AR. Malnutrition and microbiota--a new relationship? Nat Rev Gastroenterol Hepatol. 2013;10:261–2. doi: 10.1038/nrgastro.2013.48. [DOI] [PubMed] [Google Scholar]
  • 146.Koletzko S, Richy F, Bontems P, Crone J, Kalach N, Monteiro ML, Gottrand F, Celinska-Cedro D, Roma-Giannikou E, Orderda G, et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut. 2006;55:1711–6. doi: 10.1136/gut.2006.091272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Goddard AF, Jessa MJ, Barrett DA, Shaw PN, Idström JP, Cederberg C, Spiller RC. Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. Gastroenterology. 1996;111:358–67. doi: 10.1053/gast.1996.v111.pm8690200. [DOI] [PubMed] [Google Scholar]
  • 148.Niehaus MD, Moore SR, Patrick PD, Derr LL, Lorntz B, Lima AA, Guerrant RL. Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. Am J Trop Med Hyg. 2002;66:590–3. doi: 10.4269/ajtmh.2002.66.590. [DOI] [PubMed] [Google Scholar]
  • 149.Lorntz B, Soares AM, Moore SR, Pinkerton R, Gansneder B, Bovbjerg VE, Guyatt H, Lima AM, Guerrant RL. Early childhood diarrhea predicts impaired school performance. Pediatr Infect Dis J. 2006;25:513–20. doi: 10.1097/01.inf.0000219524.64448.90. [DOI] [PubMed] [Google Scholar]
  • 150.Berkman DS, Lescano AG, Gilman RH, Lopez SL, Black MM. Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet. 2002;359:564–71. doi: 10.1016/S0140-6736(02)07744-9. [DOI] [PubMed] [Google Scholar]
  • 151.Lozoff B, Jimenez E, Wolf AW. Long-term developmental outcome of infants with iron deficiency. N Engl J Med. 1991;325:687–94. doi: 10.1056/NEJM199109053251004. [DOI] [PubMed] [Google Scholar]
  • 152.Lozoff B, Jimenez E, Smith JB. Double burden of iron deficiency in infancy and low socioeconomic status: a longitudinal analysis of cognitive test scores to age 19 years. Arch Pediatr Adolesc Med. 2006;160:1108–13. doi: 10.1001/archpedi.160.11.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Muhsen K, Ornoy A, Akawi A, Alpert G, Cohen D. An association between Helicobacter pylori infection and cognitive function in children at early school age: a community-based study. BMC Pediatr. 2011;11:43–51. doi: 10.1186/1471-2431-11-43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154.Beydoun MA, Beydoun HA, Shroff MR, Kitner-Triolo MH, Zonderman AB. Helicobacter pylori seropositivity and cognitive performance among US adults: evidence from a large national survey. Psychosom Med. 2013;75:486–96. doi: 10.1097/PSY.0b013e31829108c3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, et al. European Helicobacter Study Group Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012;61:646–64. doi: 10.1136/gutjnl-2012-302084. [DOI] [PubMed] [Google Scholar]
  • 156.Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, Colvin DC, Romero-Gallo J, Suarez G, Loh J, Slaughter JC, et al. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest. 2013;123:479–92. doi: 10.1172/JCI64373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 157.Morgan DR, Torres J, Sexton R, Herrero R, Salazar-Martínez E, Greenberg ER, Bravo LE, Dominguez RL, Ferreccio C, Lazcano-Ponce EC, et al. Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. JAMA. 2013;309:578–86. doi: 10.1001/jama.2013.311. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut Microbes are provided here courtesy of Taylor & Francis

RESOURCES